3 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Vemurafenib showed efficacy in children with recurrent or progressive BRAFV600E-mutant brain tumors with acceptable toxicity, however, the rebound rate of 23% warrants further investigation.
The NV-Reason-CT model, a generative vision--language model for chest and abdominal CT combining native 3D visual encoding with radiologist-guided reasoning, and the model and training code are released to support reproducible research on explainable AI for volumetric medical imaging.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
